A detailed history of Jefferies Financial Group Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 33,209 shares of ZLAB stock, worth $576,840. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,209
Previous 62,824 47.14%
Holding current value
$576,840
Previous $1.72 Million 69.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$15.95 - $26.8 $472,359 - $793,682
-29,615 Reduced 47.14%
33,209 $532,000
Q4 2023

Feb 13, 2024

BUY
$22.97 - $30.58 $1.12 Million - $1.48 Million
48,543 Added 339.91%
62,824 $1.72 Million
Q3 2023

Nov 14, 2023

BUY
$22.72 - $31.49 $49,007 - $67,923
2,157 Added 17.79%
14,281 $347,000
Q2 2023

Aug 14, 2023

BUY
$25.3 - $39.67 $306,737 - $480,959
12,124 New
12,124 $336,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $1.7B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.